<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CDD0F60B-FB27-4CAF-8F9C-AF2F651A372A"><gtr:id>CDD0F60B-FB27-4CAF-8F9C-AF2F651A372A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Conway</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190074193"><gtr:id>C0C59410-4C4A-4E78-BB00-65BFA2F43479</gtr:id><gtr:title>Importance of parasitaemia in determining the longevity of antibody responses to Plasmodium falciparum antigens</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190074193</gtr:grantReference><gtr:abstractText>Malaria is a major cause of severe illness in children in The Gambia, and much of Africa. We would like to learn more about the immunity (protection in the body) to malaria and especially how long this lasts in young children. We would like to understand how important malaria parasites in the blood are for keeping immunity strong.In the study, 75 children will be selected by chance and given Fansidar to remove any parasites in the blood and 75 children not be given Fansidar at this time will as control. Subsequently, children will be visited at home weekly, for the next 14 weeks to record the health of the child. Every other week a finger prick blood sample will be taken to look for malaria parasites and measure immunity to understand the processes involved in protecting against malaria.</gtr:abstractText><gtr:technicalSummary>The level of circulating, malaria-specific antibody provides an important measure of immunity to the parasite, and passive transfer of specific antibody has a significant protective effect against P falciparum infection. Previous studies suggest that antibodies to P.falciparum are short-lived, however, in the endemic regions many individuals maintain a low-level asymptomatic parasitaemia that may persist for months. Our aim is to quantify the decline of antibody in children under 5 years and assess the importance of asymptomatic parasitaemia on the longevity and quality of antibody to a number of important anti-P.falciparum antigens. All recombinant antigens used in this study are currently being suggested as vaccine candidates.Up to 750 young children in villages in Farafenni household registration survey (HRS) will be screened by ELISA for antibodies to P falciparum antigens. A total of 150 children with antibodies to one or more P.falciparum antigens will be randomised into two groups to receive either no treatment or treatment with suphadoxine/pyrimethamine (S/P). Subsequently, children will be visited at home weekly, for the next 14 weeks. In weeks 2, 4, 6, 8, 10, 12 and 14, finger prick blood will be collected and used for ELISA, thick films, and PCR for parasite detection. This proposal thus adds further depth to the antibody longevity measure, by determining whether persistent infection plays a role in antibody maintenance.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>293158</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Open days in Gambia</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>9AE1E94D-23BD-4C0D-8D99-9CEF5C90A7B4</gtr:id><gtr:impact>Describing process of research on malaria and its relevance to public health in The Gambia

Increased understanding and appreciation of the importance of research and the means whereby this is conducted</gtr:impact><gtr:outcomeId>F69C56F8135</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DBA24A9A-0BDF-4314-BAD9-0F53418B04DE</gtr:id><gtr:title>Continued decline of malaria in The Gambia with implications for elimination.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f0c436672f5d43f5d7799e36196b76b"><gtr:id>8f0c436672f5d43f5d7799e36196b76b</gtr:id><gtr:otherNames>Ceesay SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>ejQgAaDneyX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4637C67-2EE0-47A4-A644-23EDAC4C118A</gtr:id><gtr:title>Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f0c436672f5d43f5d7799e36196b76b"><gtr:id>8f0c436672f5d43f5d7799e36196b76b</gtr:id><gtr:otherNames>Ceesay SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>A7EC45144CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A46D9E9C-A9D0-400D-9877-7A17469B2639</gtr:id><gtr:title>Serology describes a profile of declining malaria transmission in Farafenni, The Gambia.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6755bcf9927bd4a9fd308ef1f5cd7e0"><gtr:id>a6755bcf9927bd4a9fd308ef1f5cd7e0</gtr:id><gtr:otherNames>van den Hoogen LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56dd4964a01133.66092871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EF3F4FB-A0B9-4EFB-AD14-914C710B8FEE</gtr:id><gtr:title>IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1540b4e6cd772ffd97446f75737ecae8"><gtr:id>1540b4e6cd772ffd97446f75737ecae8</gtr:id><gtr:otherNames>Kinyanjui SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>968EDA695F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDC68115-C7CF-40B6-974D-832095013BD6</gtr:id><gtr:title>Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e6ecc08d3ab74e6d00464677ed298a8"><gtr:id>5e6ecc08d3ab74e6d00464677ed298a8</gtr:id><gtr:otherNames>Satoguina J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>084276B44DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD1CF5D-B7F9-4945-8897-870AB250EF3A</gtr:id><gtr:title>Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0356e0029d68524a9aeb5a902e276a5c"><gtr:id>0356e0029d68524a9aeb5a902e276a5c</gtr:id><gtr:otherNames>Est?vez PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>Du1CLQNcciE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FB58DC9-BE67-409A-A88C-96024B3F045C</gtr:id><gtr:title>Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a35b0feabbadb42f128e56fe95518cc1"><gtr:id>a35b0feabbadb42f128e56fe95518cc1</gtr:id><gtr:otherNames>Duah NO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>6762ED85F7B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE5CA3AC-5FB4-41B2-9BBA-5729F92F3703</gtr:id><gtr:title>Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a35b0feabbadb42f128e56fe95518cc1"><gtr:id>a35b0feabbadb42f128e56fe95518cc1</gtr:id><gtr:otherNames>Duah NO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>BB9EAE678E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FEDFC38-54B6-4F18-8867-B524095849F7</gtr:id><gtr:title>Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67d91ab035bddc2f3ddf87ff98fb8c23"><gtr:id>67d91ab035bddc2f3ddf87ff98fb8c23</gtr:id><gtr:otherNames>Akpogheneta OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>4AB0BFFB648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF7BD495-FEE8-4E08-8B32-6F7B261AB87D</gtr:id><gtr:title>Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67d91ab035bddc2f3ddf87ff98fb8c23"><gtr:id>67d91ab035bddc2f3ddf87ff98fb8c23</gtr:id><gtr:otherNames>Akpogheneta OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>7D90B141CD0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190074193</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>